Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

Charles River Laboratories International Inc (NYSE:CRL) stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings. The life science tools company reported: Revenue of $984.2 million, a decrease of 2.7% year over year, beating the consensus of…